MarketPeel
Insider Trading Intelligence
ST

Shawn Tomasello

CABA
DIRECTOR · CABALETTA BIO, INC. · CIK 0001617239
FILING MIX · LIFETIME89%/11%
BUYS
16
SELLS
2
TOTAL VALUE
$50.3K
COMPANIES
4
ACTIVE SINCE
May 2020
HOLDINGS NOW
125,035
AVG SELL PX
TRADE KIND
SHOWING 18 / 18
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pending
Forward-return performance of every backtestable P/S trade by Shawn Tomasello, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+21.80%+1.46%+20.33%+20.33%
14d1+100.00%+7.26%+0.12%+7.15%+7.15%
30d1+100.00%+24.36%+0.59%+23.77%+23.77%
60d1+100.00%+20.51%-4.38%+24.89%+24.89%
90d1+100.00%+33.76%+2.73%+31.04%+31.04%
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CABA · 22,000 shares · as of Jun 9, 2026
011,00022,00033,00044,000202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 16 buys / 2 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
50,00050,000Jun 17, 2026Jun 18, 2026View →
CABA
CABALETTA BIO, INC.
PURCHASEGRANT
Stock grant
22,00022,000Jun 9, 2026Jun 10, 2026View →
CABA
CABALETTA BIO, INC.
PURCHASE
22,725$2.21$50.3K22,725Jan 21, 2026Jan 21, 2026View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,50022,500Jun 17, 2025Jun 20, 2025View →
CABA
CABALETTA BIO, INC.
PURCHASEGRANT
Stock grant
22,00022,000Jun 9, 2025Jun 9, 2025View →
CABA
CABALETTA BIO, INC.
PURCHASEGRANT
Stock grant
22,00022,000May 19, 2025May 19, 2025View →
CABA
CABALETTA BIO, INC.
SALE
22,0000May 19, 2025May 19, 2025View →
CABA
CABALETTA BIO, INC.
SALE
44,0000May 19, 2025May 19, 2025View →
CABA
CABALETTA BIO, INC.
PURCHASEGRANT
Stock grant
44,00044,000May 19, 2025May 19, 2025View →
CABA
CABALETTA BIO, INC.
PURCHASEGRANT
Stock grant
22,00022,000Jun 3, 2024Jun 4, 2024View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,50022,500May 21, 2024May 23, 2024View →
CABA
CABALETTA BIO, INC.
PURCHASEGRANT
Stock grant
44,00044,000Jul 21, 2023Jul 24, 2023View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,50022,500May 23, 2022May 25, 2022View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
10,00010,000Jun 7, 2021Jun 8, 2021View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,50022,500May 17, 2021May 19, 2021View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
10,00010,000Jun 8, 2020Jun 9, 2020View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
35,93835,938May 20, 2020May 22, 2020View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
43,03543,035May 20, 2020May 22, 2020View →
Other insiders · CABA
Loading peer insiders…
About this filer
CIK 0001617239
ROLE
Director
PRIMARY
CABA
COMPANIES
4
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001617239DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback